Terms: = Cervical cancer AND CHD4, Mi2-BETA, 1108, ENSG00000111642, Mi-2b, DKFZp686E06161, Q14839 AND Treatment
5 results:
1. A Novel Prognostic Risk Model for cervical cancer Based on Immune Checkpoint HLA-G-Driven Differentially Expressed Genes.
Xu HH; Wang HL; Xing TJ; Wang XQ
Front Immunol; 2022; 13():851622. PubMed ID: 35924232
[TBL] [Abstract] [Full Text] [Related]
2. Reduction of overtreatment without reduction of overdiagnosis in patients with differentiated thyroid cancer: mission impossible.
Oblak T; Perhavec A; Hocevar M; Peric B
Langenbecks Arch Surg; 2021 Sep; 406(6):2011-2017. PubMed ID: 34097134
[TBL] [Abstract] [Full Text] [Related]
3. Sequential magnetic resonance imaging of cervical cancer: the predictive value of absolute tumor volume and regression ratio measured before, during, and after radiation therapy.
Wang JZ; Mayr NA; Zhang D; Li K; Grecula JC; Montebello JF; Lo SS; Yuh WT
Cancer; 2010 Nov; 116(21):5093-101. PubMed ID: 20629080
[TBL] [Abstract] [Full Text] [Related]
4. Evaluating the gene-expression profiles of HeLa cancer cells treated with activated and nonactivated poly(amidoamine) dendrimers, and their DNA complexes.
Kuo JH; Liou MJ; Chiu HC
Mol Pharm; 2010 Jun; 7(3):805-14. PubMed ID: 20394435
[TBL] [Abstract] [Full Text] [Related]
5. Radiation-induced tumors of the head and neck following childhood irradiation. Prospective studies.
Schneider AB; Shore-Freedman E; Ryo UY; Bekerman C; Favus M; Pinsky S
Medicine (Baltimore); 1985 Jan; 64(1):1-15. PubMed ID: 3965855
[TBL] [Abstract] [Full Text] [Related]
